SPRING PHARMACEUTICAL GROUP, INC.: 10-Q filed 2013-02-14

Name: SPRING PHARMACEUTICAL GROUP, INC.: 10-Q filed 2013-02-14
Creator: SPRING PHARMACEUTICAL GROUP, INC.
License: https://creativecommons.org/licenses/by/4.0/

What SPRING PHARMACEUTICAL GROUP, INC. reported in its quarterly report filed 2013-02-14 (fiscal Q3 2012): 31 published measures, 91 facts as tagged in accession 0001144204-13-008541.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-02-14
Fiscal period: fiscal Q3 2012
Accession: 0001144204-13-008541 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All SPRING PHARMACEUTICAL GROUP, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-12-31	57,540,021	USD
At 2012-03-31	53,008,384	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2012-12-31	2,467,151	USD
At 2012-03-31	11,317,387	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2012-12-31	55,072,870	USD
At 2012-09-30	49,949,155	USD
At 2012-06-30	43,907,829	USD
At 2012-03-31	41,690,997	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2013-02-11	22,146,240	USD
At 2012-12-31	27,314,507	USD
At 2012-03-31	22,146,240	USD
At 2012-02-29	22,146,240	USD
At 2011-12-31	18,443,850	USD
At 2011-12-30	19,697,004	USD
At 2011-09-30	16,316,460	USD
At 2011-06-30	16,316,460	USD
At 2011-03-31	6,046,804	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	4,648,852	USD	92
2012-04-01 to 2012-12-31	13,071,667	USD	275
2012-07-01 to 2012-09-30	6,170,105	USD	92
2012-04-01 to 2012-06-30	2,252,710	USD	91
2011-04-01 to 2011-12-31	2,078,782	USD	275
2011-10-01 to 2011-12-30	-1,434,396	USD	91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	4,985,291	USD	275
2011-04-01 to 2011-12-31	10,718,912	USD	275

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	73,502	USD	275
2011-04-01 to 2011-12-31	14,704,423	USD	275

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	-73,502	USD	275
2011-04-01 to 2011-12-31	830,208	USD	275

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	31,610,679	shares	92
2011-10-01 to 2011-12-30	31,610,679	shares	91

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	258,827	USD	92
2012-04-01 to 2012-12-31	1,585,251	USD	275
2011-04-01 to 2011-12-31	2,283,837	USD	275
2011-10-01 to 2011-12-30	1,112,777	USD	91

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2012-12-31	9,495,483	USD
At 2012-03-31	9,663,338	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	5,000	USD	275
2011-04-01 to 2011-12-31	0	USD	275

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	1,011,963	USD	92
2012-04-01 to 2012-12-31	6,276,896	USD	275
2011-04-01 to 2011-12-31	7,471,801	USD	275
2011-10-01 to 2011-12-30	2,931,698	USD	91

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-12-31	29,896,475	USD
At 2012-03-31	24,261,553	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-12-31	2,467,151	USD
At 2012-03-31	5,785,495	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2012-12-31	0	USD
At 2012-03-31	115,938	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	2,460,335	USD	92
2012-04-01 to 2012-12-31	5,876,257	USD	275
2011-04-01 to 2011-12-31	7,111,660	USD	275
2011-10-01 to 2011-12-30	2,468,061	USD	91

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2012-12-31	2,561,052	USD
At 2012-03-31	1,978,488	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	3,472,298	USD	92
2012-04-01 to 2012-12-31	12,153,153	USD	275
2011-04-01 to 2011-12-31	14,583,461	USD	275
2011-10-01 to 2011-12-30	5,399,759	USD	91

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	723,790	USD	92
2012-04-01 to 2012-12-31	1,272,490	USD	275
2011-04-01 to 2011-12-31	577,514	USD	275
2011-10-01 to 2011-12-30	183,693	USD	91

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-12-31	29,575,523	shares
At 2012-03-31	73,780,610	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2012-12-31	4,180,183	USD
At 2012-03-31	36,879,643	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2012-12-31	3,646,362	USD
At 2012-03-31	3,341,156	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2012-12-31	10,905,844	USD
At 2012-03-31	10,812,557	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2012-12-31	1,410,361	USD
At 2012-03-31	1,149,219	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2012-12-31	17,927,772	USD
At 2012-03-31	18,863,510	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	5,123,715	USD	92
2012-04-01 to 2012-12-31	13,376,873	USD	275
2011-04-01 to 2011-12-31	2,926,707	USD	275
2011-10-01 to 2011-12-30	-1,436,120	USD	91

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	1,184,227	USD	92
2012-04-01 to 2012-12-31	2,387,125	USD	275
2011-04-01 to 2011-12-31	4,028,897	USD	275
2011-10-01 to 2011-12-30	1,570,674	USD	91

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	84,813	USD	92
2012-04-01 to 2012-12-31	261,143	USD	275
2011-04-01 to 2011-12-31	155,283	USD	275
2011-10-01 to 2011-12-30	27,885	USD	91

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	115,938	USD	275
2011-04-01 to 2011-12-31	0	USD	275

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	-582,564	USD	275
2011-04-01 to 2011-12-31	-2,424,798	USD	275

Inspect the source

Entity: SPRING PHARMACEUTICAL GROUP, INC. / CIK 0000847464
Captured: 2026-09-22 19:31 UTC
SEC response SHA-256: 21fd63bfa4a441f5dd22dbcc8093e88a40c5d63950c8b6833c77a7b4245f4dc7

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000847464.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))